Mesenchymal stem cells (MSCs) are adult stem cells that were initially isolated from bone
marrow. However, subsequent research has shown that other adult tissues also contain …

Mesenchymal Stem Cells or Marrow Stromal Cells (MSCs) have long been viewed as a
potent tool for regenerative cell therapy. MSCs are easily accessible from both healthy donor …

Background Infusion of PDA-001, a preparation of mesenchymal-like cells derived from full-
term human placenta, is a new approach in the treatment of patients with multiple sclerosis …

Traumatic brain injury (TBI) is soon predicted to become the third leading cause of death
and disability worldwide. After the primary injury, a complex set of secondary injuries …

Introduction Effective therapies for obesity and diabetes are still lacking. The aim of this
study was to evaluate whether a single intravenous infusion of syngeneic adipose-derived …

We have chosen to test the safety of human intracerebroventricular (ICV) brain injections of
autologous non-genetically-modified adipose-derived stromal vascular fraction (ADSVF). In …

More than 6.5 million patients are burdened by the physical, cognitive, and psychosocial
deficits associated with traumatic brain injury (TBI) in the US Despite extensive efforts to …

Ischemic brain injury is associated with a high rate of mortality and disability with no effective
therapeutic strategy. Recently, a growing number of studies are focusing on mesenchymal …

White matter degeneration is an important pathophysiological event of the central nervous
system that is collectively characterized by demyelination, oligodendrocyte loss, axonal …

Multiple sclerosis (MS) is a common neurodegenerative disease and remains an unmet
clinical challenge. In MS, an autoimmune response leads to immune cell infiltration …